查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1697641

AI药物研发及临床试验市场:2025-2035年

AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035
出版日期: | 出版商: Visiongain | 英文 285 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2035 年，全球 AI 药物发现和临床试验市场规模将以 24.1% 的复合年增长率增长。

更快的药物开发时间和成本效益将推动市场发展：

推动AI药物发现和临床试验市场的关键因素包括更快的药物开发时间、降低的研究成本和提高的营运效率。人工智慧技术简化了药物发现的各个阶段，包括标靶识别、分子筛选和临床试验优化，从而实现更快、更具成本效益的药物开发。此外，人工智慧驱动平台的进步，例如分子设计的生成模型和患者招募的预测分析，预计将进一步推动市场成长。

2025 年 3 月 24 日，牛津药物发现研究所的研究人员采用人工智慧资料库来加速阿兹海默症的药物发现。透过高效分析大量生物医学数据，我们确定了54个与免疫系统相关的基因，大大缩短了基因评估所需的时间，并加快了有前景的药物标靶的识别。

2025年3月21日，阿斯特捷利康宣布将在五年内投资25亿美元在北京建立一个拥有人工智慧和资料科学实验室的研究和製造中心。该计划强调了该公司致力于利用人工智慧加强早期研发和临床开发、加速药物发现并降低相关成本。

2025 年 1 月 8 日，美国超微公司 (AMD) 向 Absci Corp 投资 2,000 万美元，以加强其基于人工智慧的药物研发活动。此次合作旨在利用 AMD 先进的运算能力来加速生物製药创新并降低成本，凸显了人工智慧在转变传统药物开发过程中日益重要的作用。

本报告提供全球AI药物研发及临床试验的市场调查，彙整市场概要，影响市场成长因素及市场机会分析，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 报告概要

第2章 摘要整理

第3章 市场概要

  • 主要调查结果
  • 市场动态
  • 影响分析
    • 市场推动要素
    • 阻碍市场要素
    • 市场机会
  • 法律规范
  • 新兴市场与大趋势
  • 波特的五力分析
  • PEST分析

第4章 AI药物研发及临床试验市场分析:各零件

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 服务
  • 软体解决方案
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第5章 AI药物研发及临床试验市场分析:各用途

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 临床试验
  • 医药品设计
  • 资料的集中与分析
  • 药物特性评估
  • 生物标记研究
  • 其他
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第6章 AI药物研发及临床试验市场分析:各治疗领域

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 肿瘤
  • 心血管疾病
  • 感染疾病
  • 神经退化性疾病
  • 代谢性疾病
  • 免疫疾病
  • 其他
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第7章 AI药物研发及临床试验市场分析:各终端用户

  • 主要调查结果
  • 市场魅力指数
  • 市场规模的转变·预测
  • 製药·生物医药品企业
  • 受託研究机构(CRO)
  • 学术机构及研究中心
    • 市场规模的转变·预测:各地区
    • 市场占有率:各地区

第8章 AI药物研发及临床试验市场分析:各地区

  • 主要调查结果
  • 市场规模的转变·预测

第9章 北美的AI药物研发及临床试验市场分析

  • 美国
  • 加拿大

第10章 欧洲的AI药物研发及临床试验市场分析

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他

第11章 亚太地区的AI药物研发及临床试验市场分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 新加坡
  • 其他

第12章 南美的AI药物研发及临床试验市场分析

  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥伦比亚
  • 其他

第13章 中东·非洲的AI药物研发及临床试验市场分析

  • 南非
  • 其他

第14章 企业简介

  • 竞争环境的分析
  • 策略性展望的分析
  • Recursion
  • Insilico Medicine
  • BenevolentAI
  • Saama Technologies
  • Tempus
  • Unlearn.ai, Inc.
  • PathAI, Inc.
  • Atomwise Inc.
  • Schrodinger, Inc.
  • AiCure
  • Aitia

第15章 总论·建议

  • Visiongain
  • 参与企业的建议
Product Code: PHA1370

The global AI-Enabled Drug Discovery and Clinical Trials market is projected to grow at a CAGR of 24.1% by 2035.

The AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Accelerated Drug Development Timelines and Cost Efficiency Driving Market Growth

Key drivers propelling the AI-enabled drug discovery and clinical trials market include the ability to reduce drug development timelines, lower research costs, and improve operational efficiency. AI technology streamlines various phases of drug discovery, including target identification, molecule screening, and clinical trial optimization, leading to faster and more cost-effective drug development. Additionally, advancements in AI-driven platforms-such as generative models for molecular design and predictive analytics for patient recruitment-are expected to further boost market growth.

For instance:

On 24th March 2025, researchers at the Oxford Drug Discovery Institute have employed AI-powered databases to accelerate Alzheimer's drug discovery. By efficiently analyzing extensive biomedical data, they identified 54 immune system-related genes for potential testing, significantly reducing the time required for gene evaluation and expediting the identification of promising drug targets.

On 21st March 2025, AstraZeneca announced a $2.5 billion investment over five years to establish a research and manufacturing center in Beijing, featuring an AI and data science laboratory. This initiative underscores the company's commitment to leveraging AI for enhancing early-stage research and clinical development, aiming to expedite drug discovery and reduce associated costs.

On 8th January 2025, Advanced Micro Devices Inc. (AMD) invested $20 million in Absci Corp to enhance AI-backed drug discovery efforts. This collaboration aims to expedite biologics innovation and reduce costs by leveraging AMD's advanced computing capabilities, highlighting the growing role of AI in transforming traditional drug development processes.

However, some large pharmaceutical companies remain hesitant to fully adopt AI-driven outsourcing due to concerns about data privacy, intellectual property loss, and reduced strategic control. Despite these concerns, the increasing complexity of drug development, combined with the rising costs of in-house operations, is pushing many companies to collaborate with AI solution providers to enhance efficiency and innovation. Emerging economies are also playing a critical role, as pharmaceutical firms seek to capitalize on lower operational costs and advanced AI technologies in these regions.

Regulatory and Data Integration Challenges to Hamper Market Growth

While the adoption of AI offers significant benefits, challenges around regulatory compliance, data integration, and standardization may slow market growth. Strict regulations governing drug approval and patient data protection require AI systems to maintain transparency and explainability, adding layers of complexity to implementation. Additionally, the need for harmonized data across diverse systems and geographies poses a logistical challenge for AI-enabled platforms.

Ensuring real-time collaboration between AI platforms and clinical trial sites also requires robust data infrastructure and seamless integration. For instance, personalized medicine and rare disease trials require advanced AI models capable of managing vast datasets while adhering to stringent regulatory frameworks. As AI adoption grows, industry stakeholders must navigate these administrative and technical challenges to fully realize the potential of AI in drug discovery and clinical trials.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the AI-enabled drug discovery and clinical trials market evolving?
  • What is driving and restraining the AI-enabled drug discovery and clinical trials market?
  • How will each AI-enabled drug discovery and clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each AI-enabled drug discovery and clinical trials submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading AI-enabled drug discovery and clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the AI-enabled drug discovery and clinical trials projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of AI-enabled drug discovery and clinical trials projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the AI-enabled drug discovery and clinical trials market?
  • Where is the AI-enabled drug discovery and clinical trials market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the AI-Enabled Drug Discovery and Clinical Trials market today, and over the next 10 years:

  • Our 285-page report provides 107 tables and 155 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI-Enabled Drug Discovery and Clinical Trials prices and recent developments.

Segments Covered in the Report

  • Component
  • Services
  • Software Solutions
  • Application
  • Clinical Trials
  • Drug Design
  • Data Aggregation and Analysis
  • Drug Characterisation
  • Biomarker Research
  • Others
  • Therapeutic Area
  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurodegenerative Diseases
  • Metabolic Diseases
  • Immunological Disorders
  • Others
  • End-users
  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organisations (CROs)
  • Academic Institutes and Research Centre

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Russia
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies profiled in the report
  • AiCure
  • Aitia
  • Atomwise Inc.
  • BenevolentAI
  • Insilico Medicine
  • PathAI, Inc.
  • Recursion
  • Saama Technologies
  • Schrodinger, Inc.
  • Tempus
  • Unlearn.ai, Inc.

Overall world revenue for AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035 in terms of value the market will surpass US$3,000 million in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035 report help you?
  • In summary, our 280+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035, with forecasts for component, application, therapeutic area, and end-users each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 24 key national markets - See forecasts for the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 11 of the major companies involved in the AI-Enabled Drug Discovery and Clinical Trials Market, 2025 to 2035.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to AI-Enabled Drug Discovery and Clinical Trials Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Growing Focus on Personalized Medicine
      • 3.3.1.2 Advancements in Technology
      • 3.3.1.3 Growing Adoption of AI in Healthcare
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 Limited Data Availability and Quality
      • 3.3.2.2 Integration with Existing Infrastructure
      • 3.3.2.3 Concerns over Data Privacy and Security
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Improved Patient Outcomes
      • 3.3.3.2 Increasing AI adoption in Pharma and Biopharma Clinical Trials
      • 3.3.3.3 Growing Collaborations and Partnerships
  • 3.4 Regulatory Framework
  • 3.5 Emerging Markets and Megatrends
  • 3.6 Porter's Five Forces Analysis
    • 3.6.1 Bargaining Power of Suppliers
    • 3.6.2 Bargaining Power of Buyers
    • 3.6.3 Competitive Rivalry
    • 3.6.4 Threat of Substitutes
    • 3.6.5 Threat of New Entrants
  • 3.7 PEST Analysis

4 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Component

  • 4.1 Key Findings
  • 4.2 Component Segment: Market Attractiveness Index
  • 4.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
  • 4.4 Services
    • 4.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 Software Solutions
    • 4.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)

5 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 5.4 Clinical Trials
    • 5.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Drug Design
    • 5.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Data Aggregation and Analysis
    • 5.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 Drug Characterization
    • 5.7.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Biomarker Research
    • 5.8.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)
  • 5.9 Others
    • 5.9.1 Market Size by Region, 2025-2035 (US$ Million)
    • 5.9.2 Market Share by Region, 2025 & 2035 (%)

6 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Therapeutic Area

  • 6.1 Key Findings
  • 6.2 Therapeutic Area Segment: Market Attractiveness Index
  • 6.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 6.4 Oncology
    • 6.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Cardiovascular Diseases
    • 6.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Infectious Diseases
    • 6.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)
  • 6.7 Neurodegenerative Diseases
    • 6.7.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.7.2 Market Share by Region, 2025 & 2035 (%)
  • 6.8 Metabolic Diseases
    • 6.8.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.8.2 Market Share by Region, 2025 & 2035 (%)
  • 6.9 Immunological Disorders
    • 6.9.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.9.2 Market Share by Region, 2025 & 2035 (%)
  • 6.10 Others
    • 6.10.1 Market Size by Region, 2025-2035 (US$ Million)
    • 6.10.2 Market Share by Region, 2025 & 2035 (%)

7 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by End-users

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
  • 7.4 Pharmaceutical & Biopharmaceutical Companies
    • 7.4.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
  • 7.5 Contract Research Organizations (CROs)
    • 7.5.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
  • 7.6 Academic Institutes and Research Centre
    • 7.6.1 Market Size by Region, 2025-2035 (US$ Million)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)

8 AI-Enabled Drug Discovery and Clinical Trials Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 9.1 Key Findings
  • 9.2 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 9.3 North America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 9.4 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 9.5 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
  • 9.6 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 9.7 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 9.8 North America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
  • 9.9 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 9.10 Canada AI-Enabled Drug Discovery and Clinical Trials Market Analysis

10 Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 10.3 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 10.4 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 10.5 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
  • 10.6 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 10.7 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 10.8 Europe AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
  • 10.9 Germany AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.10 UK AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.11 France AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.12 Italy AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.13 Spain AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.14 Russia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 10.15 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Analysis

11 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 11.3 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 11.4 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 11.5 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
  • 11.6 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 11.7 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 11.8 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
  • 11.9 China AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.10 Japan AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.11 India AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.12 Australia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.13 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.14 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 11.15 Rest of Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Analysis

12 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 12.3 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 12.4 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 12.5 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
  • 12.6 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 12.7 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 12.8 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
  • 12.9 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.10 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.11 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.12 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 12.13 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Analysis

13 MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • 13.3 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Country, 2025, 2030 & 2035 (US$ Million)
  • 13.4 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Country
  • 13.5 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Component
  • 13.6 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Application
  • 13.7 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by Therapeutic Area
  • 13.8 MEA AI-Enabled Drug Discovery and Clinical Trials Market Size Estimation and Forecast by End-users
  • 13.9 GCC AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 13.10 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Analysis
  • 13.11 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2024
  • 14.2 Strategic Outlook
  • 14.3 Recursion
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2020-2024
      • 14.3.3.2 R&D, 2020-2024
    • 14.3.4 Product/Service Benchmarking
    • 14.3.5 Strategic Outlook
    • 14.3.6 SWOT Analysis
  • 14.4 Insilico Medicine
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Product/Service Benchmarking
    • 14.4.4 Strategic Outlook
    • 14.4.5 SWOT Analysis
  • 14.5 BenevolentAI
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Product/Service Benchmarking
    • 14.5.4 Strategic Outlook
    • 14.5.5 SWOT Analysis
  • 14.6 Saama Technologies
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Product/Service Benchmarking
    • 14.6.4 Strategic Outlook
  • 14.7 Tempus
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
      • 14.7.2.1 Business Segment Market Shares, 2024
    • 14.7.3 Product/Service Benchmarking
    • 14.7.4 Strategic Outlook
    • 14.7.5 SWOT Analysis
  • 14.8 Unlearn.ai, Inc.
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Product/Service Benchmarking
    • 14.8.4 Strategic Outlook
  • 14.9 PathAI, Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Product/Service Benchmarking
    • 14.9.4 Strategic Outlook
  • 14.10 Atomwise Inc.
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Product/Service Benchmarking
  • 14.11 Schrodinger, Inc.
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2020-2024
      • 14.11.3.2 R&D, 2020-2024
      • 14.11.3.3 Business Segment Market Shares, 2024
    • 14.11.4 Product/Service Benchmarking
    • 14.11.5 Strategic Outlook
    • 14.11.6 SWOT Analysis
  • 14.12 AiCure
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Product/Service Benchmarking
    • 14.12.4 Strategic Outlook
  • 14.13 Aitia
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Product/Service Benchmarking
    • 14.13.4 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 AI-Enabled Drug Discovery and Clinical Trials Market Snapshot, 2025 & 2035 (US$ Million, CAGR %)
  • Table 2 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 3 Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 4 Software Solutions Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 5 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 6 Clinical Trials Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 7 Drug Design Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 8 Data Aggregation and Analysis Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 9 Drug Characterization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 10 Biomarker Research Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 11 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 12 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 13 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 14 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 15 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 16 Neurodegenerative Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 17 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 18 Immunological Disorders Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 20 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 21 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 22 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 23 Academic Institutes and Research Centre Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 24 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 25 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 26 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Indication, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 27 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 28 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 29 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 30 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 31 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 32 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 33 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 34 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 35 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 36 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 37 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 38 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 39 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 40 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 41 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 42 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 43 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 44 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 45 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 46 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 47 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 48 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 49 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 50 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 51 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 52 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 53 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 54 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 55 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 56 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 57 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 58 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 59 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 60 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 61 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 62 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 63 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 64 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 65 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 66 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 67 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 68 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 69 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 70 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 71 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 72 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 73 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
  • Table 74 Strategic Outlook
  • Table 75 Recursion: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Recursion: Product/Service Benchmarking
  • Table 77 Recursion: Strategic Outlook
  • Table 78 Insilico Medicine: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Insilico Medicine: Product/Service Benchmarking
  • Table 80 Insilico Medicine: Strategic Outlook
  • Table 81 BenevolentAI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 BenevolentAI: Product/Service Benchmarking
  • Table 83 BenevolentAI: Strategic Outlook
  • Table 84 Saama Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Saama Technologies: Product/Service Benchmarking
  • Table 86 Saama Technologies: Strategic Outlook
  • Table 87 Tempus: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Tempus: Product/Service Benchmarking
  • Table 89 Tempus: Strategic Outlook
  • Table 90 Unlearn.ai, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Unlearn.ai, Inc.: Product/Service Benchmarking
  • Table 92 Unlearn.ai, Inc.: Strategic Outlook
  • Table 93 PathAI, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 PathAI, Inc.: Product/Service Benchmarking
  • Table 95 PathAI, Inc.: Strategic Outlook
  • Table 96 Atomwise Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Atomwise Inc.: Product/Service Benchmarking
  • Table 98 Schrodinger, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Schrodinger, Inc.: Product/Service Benchmarking
  • Table 100 Schrodinger, Inc.: Strategic Outlook
  • Table 101 AiCure: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 AiCure: Product/Service Benchmarking
  • Table 103 AiCure: Strategic Outlook
  • Table 104 Aitia: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Aitia: Product/Service Benchmarking
  • Table 106 Aitia: Strategic Outlook

List of Figures

  • Figure 1 AI-Enabled Drug Discovery and Clinical Trials Market Segmentation
  • Figure 2 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
  • Figure 3 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
  • Figure 4 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
  • Figure 5 AI-Enabled Drug Discovery and Clinical Trials Market by End-users: Market Attractiveness Index
  • Figure 6 AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index by Region
  • Figure 7 AI-Enabled Drug Discovery and Clinical Trials Market: Market Dynamics
  • Figure 8 AI-Enabled Drug Discovery and Clinical Trials Market: Impact Analysis
  • Figure 9 AI-Enabled Drug Discovery and Clinical Trials Market: Porter's Five Forces Analysis
  • Figure 10 AI-Enabled Drug Discovery and Clinical Trials Market: PEST Analysis
  • Figure 11 AI-Enabled Drug Discovery and Clinical Trials Market by Component: Market Attractiveness Index
  • Figure 12 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
  • Figure 13 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025, 2030, 2035 (%)
  • Figure 14 Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 15 Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 16 Software Solutions Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 17 Software Solutions Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 18 AI-Enabled Drug Discovery and Clinical Trials Market by Application: Market Attractiveness Index
  • Figure 19 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
  • Figure 20 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025, 2030, 2035 (%)
  • Figure 21 Clinical Trials Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 22 Clinical Trials Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 23 Drug Design Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 24 Drug Design Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 25 Data Aggregation and Analysis Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 26 Data Aggregation and Analysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 27 Drug Characterization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 28 Drug Design Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 29 Biomarker Research Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 30 Biomarker Research Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 31 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 32 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 33 AI-Enabled Drug Discovery and Clinical Trials Market by Therapeutic Area: Market Attractiveness Index
  • Figure 34 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
  • Figure 35 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025, 2030, 2035 (%)
  • Figure 36 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 37 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 38 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 39 Cardiovascular Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 40 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 41 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 42 Neurodegenerative Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 43 Neurodegenerative Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 44 Metabolic Diseases Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 45 Metabolic Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 46 Immunological Disorders Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 47 Immunological Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 48 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 49 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 50 AI-Enabled Drug Discovery and Clinical Trials Market by End-users: Market Attractiveness Index
  • Figure 51 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 52 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 53 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 54 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 55 Contract Research Organizations (CROs) Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 56 Contract Research Organizations (CROs) Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 57 Academic Institutes and Research Centre Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 58 Academic Institutes and Research Centre Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 59 AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
  • Figure 60 AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Region 2025, 2030, 2035 (%)
  • Figure 61 AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025-2035 (US$ Million, AGR %)
  • Figure 62 North America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 63 North America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 64 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 65 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 66 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
  • Figure 67 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
  • Figure 68 North America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
  • Figure 69 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
  • Figure 70 North America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
  • Figure 71 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
  • Figure 72 North America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 73 North America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 74 U.S. AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 75 Canada AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 76 Europe AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 77 Europe AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 78 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 79 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 80 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
  • Figure 81 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
  • Figure 82 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
  • Figure 83 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
  • Figure 84 Europe Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
  • Figure 85 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Study Design, 2025 & 2035 (%)
  • Figure 86 Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 87 Europe AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 88 Germany AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 89 UK AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 90 France AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 91 Italy AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 92 Spain AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 93 Russia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 94 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 95 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 96 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 97 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 98 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 99 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
  • Figure 100 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
  • Figure 101 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
  • Figure 102 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 103 Asia-Pacific Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
  • Figure 104 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
  • Figure 105 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 106 Asia-Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
  • Figure 107 China AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 108 Japan AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 109 India AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 110 Australia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 111 South Korea AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 112 Singapore AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 113 Rest of Europe AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 114 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 115 Latin America AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 116 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 117 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 118 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
  • Figure 119 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
  • Figure 120 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
  • Figure 121 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 122 Latin America Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
  • Figure 123 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
  • Figure 124 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 125 Latin America AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
  • Figure 126 Brazil AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 127 Mexico AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 128 Argentina AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 129 Colombia AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 130 Rest of Latin America AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 131 MEA AI-Enabled Drug Discovery and Clinical Trials Market Attractiveness Index
  • Figure 132 MEA AI-Enabled Drug Discovery and Clinical Trials Market by Region, 2025, 2030 & 2035 (US$ Million)
  • Figure 133 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Country, 2025-2035 (US$ Million, AGR %)
  • Figure 134 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 135 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Component, 2025-2035 (US$ Million, AGR %)
  • Figure 136 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Component, 2025 & 2035 (%)
  • Figure 137 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by Application, 2025-2035 (US$ Million, AGR %)
  • Figure 138 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Application, 2025 & 2035 (%)
  • Figure 139 MEA Ai-Enabled Drug Discovery and Clinical Trials Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
  • Figure 140 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
  • Figure 141 MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
  • Figure 142 MEA AI-Enabled Drug Discovery and Clinical Trials Market Share Forecast by End-users, 2025 & 2035 (%
  • Figure 143 GCC AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 144 South Africa AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 145 Rest of MEA AI-Enabled Drug Discovery and Clinical Trials Market Forecast, 2025-2035 (US$ Million, AGR %)
  • Figure 146 AI-Enabled Drug Discovery and Clinical Trials Market: Company Share/Ranking, 2024
  • Figure 147 Recursion: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 148 Recursion: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 149 Recursion: SWOT Analysis
  • Figure 150 Insilico Medicine: SWOT Analysis
  • Figure 151 BenevolentAI: SWOT Analysis
  • Figure 152 Tempus: Business Segment Market Shares, 2024
  • Figure 153 Tempus: SWOT Analysis
  • Figure 154 Schrodinger, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR%)
  • Figure 155 Schrodinger, Inc.: R&D, 2020-2024 (US$ Million, AGR%)
  • Figure 156 Schrodinger, Inc.: Business Segment Market Shares, 2024
  • Figure 157 Schrodinger, Inc.: SWOT Analysis